Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Large Decline in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 2,000 shares, a decline of 28.6% from the January 31st total of 2,800 shares. Based on an average daily volume of 700 shares, the days-to-cover ratio is currently 2.9 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY stock remained flat at $54.80 on Wednesday. 152 shares of the stock traded hands, compared to its average volume of 849. Hikma Pharmaceuticals has a 1 year low of $46.16 and a 1 year high of $59.26. The company’s fifty day moving average price is $53.99 and its 200-day moving average price is $51.61.

Hikma Pharmaceuticals Increases Dividend

The firm also recently declared a dividend, which will be paid on Monday, May 12th. Shareholders of record on Friday, March 21st will be paid a $0.94 dividend. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.62. The ex-dividend date of this dividend is Friday, March 21st. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is presently 10.34%.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.